# FDA Inspection 1175099 - Cell Therapy and Graft Engineering, RUSH University Medical Center - May 25, 2022

Source: https://www.keypedia.com/records/fda_inspections/cell-therapy-and-graft-engineering-rush-university-medical-center/4beada7a-586a-4766-837d-075aa8833b8b
Source feed: FDA_Inspections

> FDA Inspection 1175099 for Cell Therapy and Graft Engineering, RUSH University Medical Center on May 25, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1175099
- Company Name: Cell Therapy and Graft Engineering, RUSH University Medical Center
- Inspection Date: 2022-05-25
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1175099 - 2022-05-25](https://www.keypedia.com/records/fda_inspections/cell-therapy-and-graft-engineering-rush-university-medical-center/f1ddbda3-c959-4023-9168-1747b3ac3133)

Company: https://www.keypedia.com/companies/cell-therapy-and-graft-engineering-rush-university-medical-center/ca3fc290-55af-4656-88bb-466cb3012bd7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d